News & Trends - Medical Technology

MTAA and APHA reflect on the latest private health insurance data

Health Industry Hub | November 18, 2020 |
[Total: 1    Average: 4/5]

MedTech News: New data shows the private health insurance participation rate increased for the first time since June 2015, but the small blip is not enough to start celebrations of a recovery just yet, warns Australian Private Hospitals Association (APHA) CEO Michael Roff.

The latest data from the Australian Prudential Regulation Authority (APRA) showed a 0.9% increase in membership (104,000 members) over the September quarter.

This report also indicates that private health insurers have increased their revenue by $129 million whilst the amount actually paid back to members has decreased by over $1.125 billion over the last 12 months.

Despite turning a half a billion dollar profit in the midst of a global pandemic, private health insurers have called on the Government to prop them up. This comes at a time when the insurance companies are only paying 89 cents in the dollar back to policy holders, and young people are questioning the value of their policies.

“While it is encouraging to see a small increase in health fund membership, these figures should be treated with caution. We know health insurers have been providing premium relief to policy holders due to COVID-19 and this may be artificially inflating the figures. We need to know if this increase will be sustained or is just a statistical anomaly,” he said.

Mr Roff said one positive in the uptick in participation in private health insurance was the increase in youth participation. 

“The biggest increase was in the 35-to-39 age bracket, followed by those 20-to-24 years old, indicating the youth discount introduced by the Federal Government may be having an impact and bringing younger people into the system.

“Notwithstanding the small increase in membership, there is a very strong case to restore the health insurance rebate for low-income earners. In the years since it was introduced the effective rebate has been reduced from 30% to less than 25%. These households face a ‘double whammy’ of increased premiums and reduced rebates because every year the value of their private health insurance rebate goes down.

“The Federal Government has an opportunity in the 2021 Budget to provide significant relief to these families and make the rebate count again.”

Mr Roff said there was a 23.5% increase in episodes of care in private hospitals this quarter, reflecting the easing of COVID-19 elective surgery restrictions. However, this was still 5.4% lower than the same quarter last year.

Whatever measures are taken to improve affordability in private health insurance, Mr Roff said they need to be considered as a matter of urgency.

“There are estimates the backlog in elective surgery resulting from COVID-19 surgical restrictions could take years to clear, even with the full capacity of the public and private systems. We need to urgently address private health insurance affordability to ensure Australians can continue to access private hospital services because the waiting times in public hospitals will just be too long,” he said.

Medical Technology Association of Australia (MTAA) CEO, Ian Burgess, has called on private health insurers to offer Aussie families a saving, and stop putting profit before patients.

Insurers must stop trying to squeeze profits out of the private health system and stop calling on the Government for a handout whilst continuing to make profits.

“MTAA’s 2017 Agreement with Health Minister, the Hon Greg Hunt MP has locked in at least $1.1 billion savings for the Australian public, now it’s up to insurers to dig into their own profits and offer savings to the Australian people. Insurers must stop choosing profit over patients.” Mr Burgess said.

“As doctors, nurses, MedTech innovators and other and essential works have pulled together to make ventilators, provide COVID-19 testing, and get Australia through the pandemic, struggling Australian families are rightly asking why private health profiteers are still raking in windfall profits”


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Pharmaceuticals

Pharma News - Novel gene therapy in advanced bowel cancer

Novel gene therapy in advanced bowel cancer

Health Industry Hub | November 27, 2020 |

Pharma News: For the first time, SAHMRI and University of Adelaide researchers are investigating gene therapy as an option to […]

More


Best Practice

Best Practice Pharma Biotech Medtech -Search for meaning more fulfilling than the pursuit of personal happiness

Search for meaning more fulfilling than the pursuit of personal happiness

Health Industry Hub | November 27, 2020 |

There is a myth in our culture that the search for meaning is some esoteric pursuit – that you have […]

More


Medical

Medical Pharma Biotech MedTech - Professor Kay Crossley wins top science award

Professor Kay Crossley wins top science award

Health Industry Hub | November 26, 2020 |

Medical News: World-renowned physiotherapist and La Trobe University Professor, Kay Crossley, has been awarded Victoria’s highest scientific honour, today receiving […]

More


News & Trends - Medical Technology

MedTech News - Growth of the surgical robotics market in Australia

Growth of the surgical robotics market in Australia

Health Industry Hub | November 25, 2020 |

In Australia, the penetration of surgical robots has been limited to a range of products that are manufactured internationally. Australia […]

More